Combination Therapy of Interferon Beta-1b and Tacrolimus: A Pilot Safety Study

Combination Therapy of Interferon Beta-1b and Tacrolimus: A Pilot Safety Study

Tacrolimus is a calcineurin inhibitor which works to induce immune suppression by preventing cytokine transcription and lymphocyte activation. Combining the immunomodulator interferon beta-1b (Betaseron) with the immunosuppressant tacrolimus (Prograf) may have the potential of additive therapeutic b...

Full description

Bibliographic Details
Main Authors:	F. Jacques, I. Gaboury, S. Christie, F. Grand'Maison
Format:	Article
Language:	English
Published:	Hindawi Limited 2012-01-01
Series:	Multiple Sclerosis International
Online Access:	http://dx.doi.org/10.1155/2012/935921

Similar Items

Determining the Zeta function of curves via p-adic cohomology and deformation theory
by: Grand'Maison, Jérôme
Published: (2008)

An «in vivo» MRI and «post-mortem» qIHC study of an APP mouse model
by: Grand'Maison, Marilyn
Published: (2013)

Le népotisme filial dans un groupe captif de macaques crabiers (Macaca fascicularis)
by: Grand'Maison, France
Published: (2017)

Génération automatique de lettres de recrutement
by: Grand'Maison, Philippe
Published: (2017)

An estimate of ice wedge volume for a High Arctic polar desert environment, Fosheim Peninsula, Ellesmere Island
by: C. Bernard-Grand'Maison, et al.
Published: (2018-11-01)

Quantification and characterization of anti-interferon beta antibodies in multiple sclerosis patients undergoing interferon beta-1b therapy
by: Gibbs, Ebrima
Published: (2009)

Quantification and characterization of anti-interferon beta antibodies in multiple sclerosis patients undergoing interferon beta-1b therapy
by: Gibbs, Ebrima
Published: (2009)

Therapy of tacrolimus combined with corticosteroids in idiopathic membranous nephropathy
by: W. Cui, et al.

Evaluating the Process and Impact of Global Health Education in a Social Accountability Perspective
by: V. Foley, et al.
Published: (2017-04-01)

Helping teachers to teach Global Health in health professional educational programs: the Sherbrooke experience
by: C. Valois, et al.
Published: (2017-04-01)

Efficacy and safety of tacrolimus in induction therapy of patients with lupus nephritis
by: Zhou TB, et al.
Published: (2019-03-01)

Effectiveness and safety of cyclophosphamide or tacrolimus therapy for idiopathic membranous nephropathy
by: Honghong Zou, et al.
Published: (2019-01-01)

Pilot Study of Ofloxacin and Interferon-Alpha Combination Therapy for Chronic Hepatitis C without Sustained Response to Initial Interferon Therapy
by: Masafumi Komatsu, et al.
Published: (1997-01-01)

Conjunctival squamous papilloma refractory to interferon α-2b in a patient on systemic immunosuppression (tacrolimus)
by: Preethi S. Ganapathy, et al.
Published: (2017-06-01)

The interferon beta therapies for treatment of relapsing–remitting multiple sclerosis: are they equally efficacious? A comparative review of open-label studies evaluating the efficacy, safety, or dosing of different interferon beta formulations alone or in combination
by: Volker Limmroth, et al.
Published: (2011-09-01)

Low autocrine interferon beta production as a gene therapy approach for AIDS: Infusion of interferon beta-engineered lymphocytes in macaques chronically infected with SIVmac251
by: Dormont Dominique, et al.
Published: (2004-09-01)

The Efficacy and Safety of Entecavir and Interferon Combination Therapy for Chronic Hepatitis B Virus Infection: A Meta-Analysis.
by: Qiao-Ling Xie, et al.
Published: (2015-01-01)

Efficacy and safety of UCB-derived or autologous CIK cells combined with interferon therapy in patients with chronic hepatitis B
by: LIU Bo
Published: (2014-09-01)

Safety of reduced dose of mycophenolate mofetil combined with tacrolimus in living-donor liver transplantation
by: Hyeyoung Kim, et al.
Published: (2014-09-01)

Association between occupational exposures and sarcoma incidence and mortality: systematic review and meta-analysis
by: D. Edwards, et al.
Published: (2021-08-01)

Development and progressive implementation of comprehensive interdisciplinary global health education in four health professional disciplines
by: Paul Grand’Maison, et al.
Published: (2016-08-01)

Enriching health-professional programs in global health: Development and implementation of an interdisciplinary and integrated approach
by: Carol Valois, et al.
Published: (2017-04-01)

Effectiveness of interferon-beta and temozolomide combination therapy against temozolomide-refractory recurrent anaplastic astrocytoma
by: Arai Hajime, et al.
Published: (2007-08-01)

Clinical and safety outcomes of conversion original tacrolimus to generic tacrolimus in Turkish kidney transplant recipients
by: Emrah Günay
Published: (2020-09-01)

Effectiveness and safety of topical tacrolimus in treatment of vitiligo
by: Ghasem Rahmatpour Rokni, et al.
Published: (2017-01-01)

Neutralizing antibodies and the biological response to interferon-beta therapy
by: Lam, Sin Man
Published: (2010)

Neutralizing antibodies and the biological response to interferon-beta therapy
by: Lam, Sin Man
Published: (2010)

Neutralizing antibodies and the biological response to interferon-beta therapy
by: Lam, Sin Man
Published: (2010)

Efficiency of tacrolimus therapy for perianal Crohn’s disease
by: B A Nanaeva, et al.
Published: (2015-06-01)

Interferon-Gamma DNA Methylation Is Affected by Mycophenolic Acid but Not by Tacrolimus after T-Cell Activation
by: Fleur S. Peters, et al.
Published: (2017-07-01)

Immunopharmacological aspects of methylprednisolone and interferon-beta therapies in multiple sclerosis
by: Boylan, M. T.
Published: (2002)

Patient satisfaction with the BETACONNECT™ autoinjector for interferon beta-1b
by: Weller I, et al.
Published: (2015-07-01)

A Comparison of Interferon-Alpha-2b Induction Therapy with Interferon-Alpha-2b Plus Ribavirin Combination Therapy for the Treatment of Chronic Hepatitis C
by: Bilgehan AYGEN, et al.
Published: (2004-09-01)

Sarcoidosis and multiple sclerosis: systemic toxicity associated with the use of interferon-beta therapy
by: C. Carbonelli, et al.
Published: (2015-12-01)

The Impact of Interferon Beta-1b Therapy on Thyroid Function and Autoimmunity Among COVID-19 Survivors
by: David Tak Wai Lui, et al.
Published: (2021-09-01)

Combination of interferon alfa-2b and ribavirin in relapsed or nonresponding chronic hepatitis C patients following interferon therapy
by: Laurentius A. Lesmana, et al.
Published: (2001-11-01)

USE OF INTERFERON BETA-1A FOR INTRAMUSCULAR ADMINISTRATION IN CHILDREN AND ADOLESCENTS WITH MULTIPLE SCLEROSIS: EFFICACY, SAFETY AND ADHERENCE TO THERAPY
by: O.V. Bykova, et al.
Published: (2009-10-01)

USE OF INTERFERON BETA-1A FOR INTRAMUSCULAR ADMINISTRATION IN CHILDREN AND ADOLESCENTS WITH MULTIPLE SCLEROSIS: EFFICACY, SAFETY AND ADHERENCE TO THERAPY
by: O.V. Bykova, et al.
Published: (2009-10-01)

Safety and Efficacy of Combination ACTHar Gel and Tacrolimus in Treatment-Resistant Focal Segmental Glomerulosclerosis and Membranous Glomerulopathy
by: James Tumlin, et al.
Published: (2017-09-01)

Interferon-beta in Pediatric Multiple Sclerosis Patients: Safety in Short-Term Prescription
by: Keivan Basiri, et al.
Published: (2012-02-01)